This drug, Dacomitinib, is for treating NSCLC. It targets specific mutations in the EGFR. Dacomitinib is an EGFR inhibitor—it stops the EGFR signaling.
There are three dose strengths: 15 mg, 30 mg, and 45 mg, and it’s in tablet form with a film coating. The doctor usually suggests you take 45 mg of the stuff once a day. The medicine comes in bottles, each holding 30 tablets.
Reviews
There are no reviews yet.